High serum C-X-C motif chemokine ligand 10 (CXCL10) levels may be associated with new onset interstitial lung disease in patients with systemic sclerosis: evidence from observational, clinical, transcriptomic and in vitro studies.

"Declaration of interests D.J. Mulder received grants from Sanofi Genzyme paid to the institution. W. Timens received consultancy fees from Merck Sharp Dohme and Bristol-Myers Squibb. The rest of the coauthors declare no conflict of interest."

"We would like to thank Jesse R Cappelle for his efforts in data extraction. We would like to thank The Ministry of Economic Affairs and Climate Policy for co-financing this project along with the Top Sector Life Sciences & Health (PPP-2019_007). We would also like to thank Sanofi-Genzyme for partially financing this project (NL8921). D.J. Mulder received grants from Sanofi Genzyme paid to the institution. W. Timens received consultancy fees from Merck Sharp Dohme and Bristol-Myers Squibb. The rest of the coauthors declare no conflict of interest."